How are ROIV cash-secured put max profit and max loss calculated?

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the ROIV cash-secured put priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 45.30%), the computed maximum profit is $157.50 per contract and the computed maximum loss is -$3,341.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a ROIV cash-secured put?

The breakeven for the ROIV cash-secured put priced on this page is roughly $33.43 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ROIV market-implied 1-standard-deviation expected move in the same options snapshot is approximately 12.99%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current ROIV implied volatility affect this cash-secured put?

ROIV ATM IV is at 45.30% with IV rank near 40.67%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

ROIV Cash-Secured Put Strategy

ROIV (Roivant Sciences Ltd.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.

ROIV (Roivant Sciences Ltd.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $26.12B, a beta of 1.13 versus the broader market, a 52-week range of 11.54-37, average daily share volume of 5.7M, a public-listing history dating back to 2020, approximately 721 full-time employees. These structural characteristics shape how ROIV stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.13 places ROIV roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a cash-secured put on ROIV?

A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.

ROIV snapshot

As of August 14, 2026, spot at $36.32, ATM IV 45.30%, IV rank 40.67%, expected move 12.99%. The cash-secured put on ROIV below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this cash-secured put structure on ROIV specifically: ROIV IV at 45.30% is mid-range versus its 1-year history, so the credit collected on a ROIV cash-secured put sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 12.99% (roughly $4.72 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ROIV expiries trade a higher absolute premium for lower per-day decay. Position sizing on ROIV should anchor to the underlying notional of $36.32 per share and to the trader's directional view on ROIV stock.

ROIV cash-secured put setup

The ROIV cash-secured put below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ROIV at $36.32 on that close, the first option leg uses a $35.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ROIV chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ROIV shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Sell 1	Put	$35.00	$1.58

ROIV cash-secured put risk and reward

Net Premium / Debit: +$157.50
Max Profit (per contract): $157.50
Max Loss (per contract): -$3,341.50
Breakeven(s): $33.43
Risk / Reward Ratio: 0.047

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.

ROIV cash-secured put payoff curve

Modeled P&L at expiration across a range of underlying prices for the cash-secured put on ROIV. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	-$3,341.50
$8.04	-77.9%	-$2,538.56
$16.07	-55.8%	-$1,735.61
$24.10	-33.6%	-$932.67
$32.13	-11.5%	-$129.72
$40.16	+10.6%	+$157.50
$48.19	+32.7%	+$157.50
$56.22	+54.8%	+$157.50
$64.25	+76.9%	+$157.50
$72.28	+99.0%	+$157.50

When traders use cash-secured put on ROIV

Cash-secured puts on ROIV earn premium while a trader waits to acquire ROIV stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning ROIV.

ROIV thesis for this cash-secured put

The market-implied 1-standard-deviation range for ROIV extends from approximately $31.60 on the downside to $41.04 on the upside. A ROIV cash-secured put lets a trader earn premium while waiting to acquire ROIV at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current ROIV IV rank near 40.67% is mid-range against its 1-year distribution, so the IV signal is neutral; the cash-secured put thesis on ROIV should anchor more to the directional view and the expected-move geometry. As a Healthcare name, ROIV options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ROIV-specific events.

ROIV cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ROIV positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ROIV alongside the broader basket even when ROIV-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on ROIV carry tail risk when realized volatility exceeds the implied move; review historical ROIV earnings reactions and macro stress periods before sizing. Always rebuild the position from current ROIV chain quotes before placing a trade.

Frequently asked questions

What is a cash-secured put on ROIV?: A cash-secured put on ROIV is the cash-secured put strategy applied to ROIV (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With ROIV stock at $36.32 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed ROIV chain strike and the premiums come straight from that session's bid/ask midpoint.
How are ROIV cash-secured put max profit and max loss calculated?: Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the ROIV cash-secured put priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 45.30%), the computed maximum profit is $157.50 per contract and the computed maximum loss is -$3,341.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ROIV cash-secured put?: The breakeven for the ROIV cash-secured put priced on this page is roughly $33.43 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ROIV market-implied 1-standard-deviation expected move in the same options snapshot is approximately 12.99%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a cash-secured put on ROIV?: Cash-secured puts on ROIV earn premium while a trader waits to acquire ROIV stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning ROIV.
How does current ROIV implied volatility affect this cash-secured put?: ROIV ATM IV is at 45.30% with IV rank near 40.67%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.